| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $330,055,051 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U01AI190394 | Latin American Center for Emerging Infectious Disease Research (LACER) | 001 | 1 | NIH | 9/20/2026 | $434,895 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U01AI190394 | Latin American Center for Emerging Infectious Disease Research (LACER) | 000 | 1 | NIH | 9/18/2026 | $951,602 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 000 | 1 | NIH | 3/19/2026 | $78,040 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01MH144705 | Cognitive Mechanisms and Neural Predictors of Intellectual Development in Autism | 000 | 1 | NIH | 9/17/2026 | $800,069 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21HD120908 | Seeing deeper: Longitudinal In-Vivo Imaging of the Nipple-Areolar Complex During Pregnancy and Lactation | 000 | 1 | NIH | 9/8/2026 | $402,704 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F30MH144910 | Neural Correlates of Memory-Based Generalization in Humans | 001 | 1 | NIH | 9/1/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F30MH144910 | Neural Correlates of Memory-Based Generalization in Humans | 000 | 1 | NIH | 9/1/2026 | $43,749 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31DC023776 | An articulatory brain-computer interface approach for restoring expressive communication to people with paralysis | 001 | 1 | NIH | 4/9/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 002 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31DC023776 | An articulatory brain-computer interface approach for restoring expressive communication to people with paralysis | 000 | 1 | NIH | 4/9/2026 | $43,752 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 001 | 1 | NIH | 3/26/2026 | $1,308 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21HD122043 | Infant Start for Telehealth: A Pilot Feasibility Study | 000 | 1 | NIH | 9/7/2026 | $442,750 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R61NS140824 | Circulating IsomiRs Predict Cause of Ischemic Stroke | 000 | 1 | NIH | 9/7/2026 | $2,346,171 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01MD020080 | Virtual Family-Centered Rounds: A Telehealth Innovation to Reduce Care Experience Disparities | 000 | 1 | NIH | 9/9/2026 | $804,259 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R34EY039557 | Noninvasive, Trial-Ready Multimodal Imaging Endpoints for Uveitis | 000 | 1 | NIH | 9/10/2026 | $483,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | DP2DC024816 | Restoring Speech with an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia | 000 | 1 | NIH | 9/4/2026 | $529,407 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01GM169397 | Integrating Language Models and Topology for Multi-Scale R-Loop Prediction | 000 | 1 | NIH | 9/2/2026 | $409,731 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00EB034768 | Downfield MR spectroscopic imaging of the human brain | 000 | 3 | NIH | 9/3/2026 | $248,999 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | AY2AX000258 | CYBORGEL: Reversible intracellular gelation for ambient storage of therapeutic cells | 000 | 1 | NIH | 9/22/2026 | $5,676,515 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F30AG099408 | Dissecting Age-related Changes in Stem Cell-based Bone-Gut Crosstalk | 001 | 1 | NIH | 9/2/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F30AG099408 | Dissecting Age-related Changes in Stem Cell-based Bone-Gut Crosstalk | 000 | 1 | NIH | 9/2/2026 | $43,752 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U18FD008962 | Animal and Veterinary Innovation Center for Minor Ruminant Drug Development: A Feasibility Assessment and Regulatory Science Framework for a National Minor Ruminant Drug Approval Partnership (MRDAP) | 000 | 1 | FDA | 9/21/2026 | $483,368 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U18FD008959 | UC Davis Innovation Center for Honey Bee Therapeutics and Regulatory Science | 000 | 1 | FDA | 9/21/2026 | $999,756 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | 90DDUC0157 | FY 26 NCC for University Center for Excellence in Developmental Disabilities (UCEDD) at the UC Davis MIND Institute | 00 | 1 | ACL | 9/17/2026 | $629,011 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DK144748 | Neonatal development of the microbiota-gut-brain axis | 000 | 1 | NIH | 8/26/2026 | $739,895 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U19FD008633 | Enhance the Capacity and Capability to Test Animal and Human Foods in the Area of Chemical Testing through the Development of Special Projects and Food and Feed Monitoring Activities | 002 | 2 | FDA | 8/6/2026 | $415,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03EB039919 | Analytic Modeling and Timing Correction in Digital-to-Analog SiPM Detectors with Cherenkov Luminescence for TOF-PET | 000 | 1 | NIH | 9/1/2026 | $80,500 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21AG098490 | Galectin-12 and neuroinflammation in Alzheimer’s disease | 000 | 1 | NIH | 8/27/2026 | $442,750 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U19FD008633 | Enhance the Capacity and Capability to Test Animal and Human Foods in the Area of Chemical Testing through the Development of Special Projects and Food and Feed Monitoring Activities | 003 | 2 | FDA | 9/29/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM163701 | Causes and consequences of genome instability and chromosome rearrangements | 000 | 1 | NIH | 5/6/2026 | $435,405 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K01DK143201 | Applying Implementation Science to Improve Transitions from Pediatric to Adult Care for Adolescents and Young Adults with Type 1 Diabetes | 000 | 1 | NIH | 5/7/2026 | $151,448 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DK140492 | A Novel Nanodrug for Metabolic Disease Treatment | 000 | 1 | NIH | 8/12/2026 | $803,565 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA301398 | Modeling extensive cellular variability in glycolytic rates using multiplexed live-cell data | 000 | 1 | NIH | 3/24/2026 | $648,177 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | UM1TR005995 | UC Davis Clinical and Translational Science Center | 001 | 1 | NIH | 9/2/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | UM1TR005995 | UC Davis Clinical and Translational Science Center | 000 | 1 | NIH | 5/12/2026 | $5,755,059 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG094076 | Subjective cognitive decline as a risk for Alzheimer's disease and vascular cognitive impairment across diverse groups | 000 | 1 | NIH | 2/19/2026 | $690,934 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03DE035523 | Cyclooxygenase signaling in neural crest migration and craniofacial development | 000 | 1 | NIH | 7/2/2026 | $301,086 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB039019 | Whole-Body PET Parametric Imaging for Pediatric Patients | 000 | 1 | NIH | 5/12/2026 | $2,238,460 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00DC021504 | Taste perception of host cues in the invasive disease vector mosquito Aedes albopictus | 000 | 3 | NIH | 1/1/2026 | $238,502 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS146486 | Functional biology of alternative promoters in the cerebral cortex | 000 | 1 | NIH | 8/20/2026 | $622,252 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03EB040241 | Systematic investigation of artifacts in deep learning-based PET image enhancement | 000 | 1 | NIH | 8/6/2026 | $80,500 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM161914 | Decoding the Mechanisms and Regulatory Networks of Plant U-Box/RING Ubiquitin Ligase Complexes under biotic stress | 000 | 1 | NIH | 3/24/2026 | $390,881 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21NS142879 | Optimization of AAV gene therapy through the unbiased, high-throughput screening of novel ITR domains in the mouse brain | 000 | 1 | NIH | 3/31/2026 | $442,750 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AR085746 | Etiology and treatment for the skeletal defects caused by Spermine Synthase deficiency | 000 | 1 | NIH | 7/7/2026 | $596,378 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB037561 | Maximizing the Performance of Whole-Body PET Scanner | 000 | 1 | NIH | 8/18/2026 | $615,615 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R25NS141153 | UC Davis NEURO Program | 000 | 1 | NIH | 5/18/2026 | $126,845 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DK148505 | The role of the alpha-cell in the effects of obesity and weight loss on glucose regulation | 000 | 1 | NIH | 8/7/2026 | $782,890 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS131379 | Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity | 000 | 2 | NIH | 3/31/2026 | $539,408 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB039074 | Advancing positron lifetime tomography for clinical translation | 000 | 1 | NIH | 8/10/2026 | $701,020 |
|
